the diagnosis and treatment of urinary tract infection (UTI)
REVOLUTIONISING
the diagnosis and treatment of urinary tract infection (UTI)
Innovative PhenUtest point-of-care test
Results in under an hour including full antimicrobial susceptibility test.
Ground-breaking technology with the potential to transform the diagnosis and treatment of urinary tract infection, a common condition associated with billions of dollars of annual healthcare costs globally. In the US alone these costs are in the order of $44bn.
Innovative PhenUtest point-of-care test
Results in under an hour including a full antimicrobial susceptibility test
Ground-breaking technology with the potential to transform the diagnosis and treatment of urinary tract infection, a common condition associated with billions of dollars of annual healthcare costs globally. In the US alone these costs are in the order of $44bn.1
Accurate Results
Proprietary technology provides accurate results in less than an hour
For use in primary care, the community and emergency care
Expected to reduce hospitalisation and slow the growth of antimicrobial resistance (AMR)
Accurate Results
Proprietary technology provides accurate results in less than an hour
For use in primary care, the community and emergency care
Expected to reduce hospitalisation and slow the growth of antimicrobial resistance (AMR)
More than
150M
UTI infections a year globally, of which >71% of patients are women2, 3
More than
150M
UTI infections a year globally, of which >71% of patients are women2, 3
Current methods are time-consuming and often inaccurate
Current gold standard test take 48+ hours to deliver full antimicrobial susceptibility test (AST) results
Current methods are time-consuming and often inaccurate
Current gold standard tests take 48+ hours to deliver full antimicrobial susceptibility test (AST) results4
Zilberberg et al., outcomes of ER visits with complicated UTIs, 2022
2.
Flores-Mireles et al., UTI epidemiology, mechanisms and treatment, 2015
3.
Simmering et al., Hospitalisations for UTI and Associated Cost, 2017
4.
Xu et al., Review of Current and Developing UTI diagnostics, 2021
This test has not been approved or cleared by the U.S. Food and Drug Administration. The performance characteristics of this test have not been established.
Innotive Diagnostics Ltd
Second Floor
Riverside South Building
Walcot Yard
Walcot Street
Bath BA1 5BG